70 results
8-K
EX-10.1
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
Product Intellectual Property has been authorized to be disclosed or has been actually disclosed by Seller or its Affiliates to any employee, consultant … on the disclosure and use of the Owned Product Intellectual Property that constitutes such trade secret. To the Knowledge of Seller, no employee, consultant
8-K
EX-99.5
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
. If the Company does hire or engage an employee of Acelyrin during such period, the Company is obligated to make a certain payment to Acelyrin
8-K
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
employees or independent contractors of Tenet. If Tenet does hire or engage an employee of Acelyrin during such period, Tenet is obligated to make a certain … in accordance with the Company’s non-employee director compensation program.
Item 7.01.
Regulation FD Disclosure.
On June 27, 2024, the Company issued a press
8-K
EX-99.4
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
contractors of the Company. If the Company does hire or engage an employee of Acelyrin during such period, the Company is obligated to make a certain
8-K
EX-99.2
ELYM
Eliem Therapeutics Inc
27 Jun 24
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
4:22pm
contractors of Tenet. If Tenet does hire or engage an employee of Acelyrin during such period, Tenet is obligated to make a certain payment to Acelyrin
8-K
EX-10.1
9rr6s 9q1
12 Jun 24
Departure of Directors or Certain Officers
4:41pm
DEFM14A
9gsq6q
4 Jun 24
Proxy related to merger
8:00am
PREM14A
0fzoel
17 May 24
Preliminary proxy related to merger
4:36pm
DEFA14A
taq3k
11 Apr 24
Additional proxy soliciting materials
8:10am
8-K
EX-10.5
e0w0onxc
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
EX-2.1
h9n0mpyxoox9tcwfme2
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
8-K
EX-10.4
6meo0
11 Apr 24
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
8:01am
S-8
v4bfh9
28 Mar 24
Registration of securities for employees
4:27pm
S-8
zzn3rdmabywov
28 Mar 24
Registration of securities for employees
4:27pm
S-8
EX-5.1
8f9i lnkz2
28 Mar 24
Registration of securities for employees
4:27pm